Brief: Gsk - Presents Positive Data To Expand Jideytro To First-Line ROS1-Positive NSCLC
BRIEF-Gsk - Presents Positive Data To Expand Jideytro To First-Line ROS1-Positive NSCLC Sept 14 (Reuters) - GSK plc GSK.L:
GSK - PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC
Source text: [https://tinyurl.com/y59pah66]
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))